All News

Pharmaceutical companies continue trial for GBP510 in conjunction with GSK’s pandemic adjuvant.

Approved indications for idelalisib include relapsed chronic lymphocytic leukemia, small lymphocytic lymphoma, and follicular B-cell non-Hodgkin lymphoma.

Patients should be encouraged to remind their primary care provider to make sure they are on schedule and do not miss any vaccinations based on their age and conditions.

Study findings could influence how drug developers consider how opioid drugs cause tolerance and respiratory depression, and it suggests an alternative approach to developing safer analgesics.

Pharmacists carry a unique responsibility in the battle that has claimed 500,000 lives in the past 2 decades.

Pharmacy Times spoke with Dr. Trishia Shaw, the Clinical Assistant Professor of Pharmacy Practice at Chicago State University College of Pharmacy, on her presentation at the NPhA conference titled “Who’s your Provider”—Updates in Provider Status for Pharmacists.

Although the average demand for tocilizumab increased by 279% during the study period, fill rates for orders by hospitals dropped from 99% to 45%.

In addition to early screening, counseling patients on preventive interventions can reduce the risk of developing prediabetes or type 2 diabetes.

The data represent teens most likely to benefit from the vaccination and are meant to offer reassurance to parents and clinicians, even with small study numbers.

Relugolix is an orally administered treatment for prostate cancer that works by blocking the pituitary gland from making luteinizing hormone and follicle-stimulating hormone.

This is the first time that the intravenous (IV) formulation of brivaracetam will be available for pediatric patients and is the only IV formulation approved for partial-onset seizures and this age group in nearly 7 years.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

Previous studies have demonstrated an association between low levels of vitamin D in the blood and pain, sensitivity to infection, fatigue, depression, and lower self-rated quality of life.

They added that side chains are linked to nitrogens in the molecular backbone, forming a structure that resists enzymes.

New research provides a further explanation for how an infection by influenza A virus followed by S. pneumoniae superinfection causes severe pneumonia and a high death rate.

Symptoms of IBD include diarrhea, fatigue, abdominal pain, cramping, blood in stool, reduced appetite, and weight loss.

In an interview with Pharmacy Times®, Sachin Nagrani, MD, medical director at the home visit and telemedicine service Heal, discusses the Biden administration's announcement that booster shots will soon be available for the Pfizer and Moderna vaccines, and what this would mean for patients and practitioners.

In the latest Student Cafe interview series, students from the University of Texas at Austin College of Pharmacy discussed the future of pharmacy after the COVID-19 pandemic.

Marketing theory is particularly useful for defining your business and your competitors.

The mutated genes in question, TET2 and DNMT3A, each influence the efficacy of treatment in different ways.

This designation could shorten the FDA review period to 8 months compared to the 12 months under Standard Review.

Pharmacy Times spoke to ASHP’s Vice President of Government Relations Tom Kraus about the recent actions from ASHP urging the HHS to allow pharmacists to provide COVID-19 prophylaxis treatment.

Immune Globulins are injections that are used to treat immunodeficiency disorders.

Cities were ranked on a 50 point scale, weighing factors including therapy session rate by state, total prescription charges by state, their grade for mandatory treatment laws by state, criminalization of mental illness by state, number of residents per 1 mental health provider by county, poor mental health days by county, and overall community wellbeing.

Peter Koshland, PharmD, CEO of Koshland Pharm and a practicing pharmacist, discusses the role of the pharmacist in ketamine therapy.

The kinase inhibitor is a promising treatment option for patients with MET exon 14 skipping mutation non–small cell lung cancer.

Silmitasertib has produced clinical benefit as a monotherapy and in combination with drugs such as gemcitabine and cisplatin.